A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants

NCT05338489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Selpercatinib
DRUG: Itraconazole
DRUG: Rifampin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]